Omega Healthcare Investors (NYSE:OHI) has been assigned a $28.00 price objective by SunTrust Banks in a research note issued to investors on Monday. The brokerage presently has a “hold” rating on the real estate investment trust’s stock. SunTrust Banks’ price target indicates a potential upside of 5.66% from the stock’s current price.

A number of other brokerages have also commented on OHI. Zacks Investment Research lowered Omega Healthcare Investors from a “hold” rating to a “sell” rating in a research note on Tuesday, January 2nd. Cantor Fitzgerald started coverage on Omega Healthcare Investors in a research note on Wednesday, December 20th. They set an “overweight” rating and a $34.00 price target on the stock. Vetr lowered Omega Healthcare Investors from a “buy” rating to a “hold” rating and set a $33.33 price target on the stock. in a research note on Thursday, October 19th. Jefferies Group reissued an “underperform” rating on shares of Omega Healthcare Investors in a research note on Thursday, December 21st. Finally, Capital One Financial started coverage on Omega Healthcare Investors in a research note on Monday, October 23rd. They set an “equal weight” rating and a $34.00 price target on the stock. Three analysts have rated the stock with a sell rating, four have given a hold rating and three have given a buy rating to the company. Omega Healthcare Investors has a consensus rating of “Hold” and an average price target of $31.85.

Shares of Omega Healthcare Investors (NYSE:OHI) traded up $0.18 during mid-day trading on Monday, hitting $26.50. The stock had a trading volume of 1,759,600 shares, compared to its average volume of 1,997,538. Omega Healthcare Investors has a 12-month low of $26.01 and a 12-month high of $35.14. The firm has a market capitalization of $5,300.00, a price-to-earnings ratio of 34.87, a price-to-earnings-growth ratio of 2.74 and a beta of 0.49. The company has a quick ratio of 3.40, a current ratio of 3.40 and a debt-to-equity ratio of 1.18.

Omega Healthcare Investors (NYSE:OHI) last announced its quarterly earnings results on Monday, October 30th. The real estate investment trust reported ($0.67) EPS for the quarter, missing the Zacks’ consensus estimate of $0.83 by ($1.50). Omega Healthcare Investors had a net margin of 17.61% and a return on equity of 3.92%. analysts forecast that Omega Healthcare Investors will post 3.21 EPS for the current year.

In other Omega Healthcare Investors news, Director Bernard J. Korman bought 100,000 shares of the stock in a transaction on Friday, December 22nd. The stock was acquired at an average cost of $26.89 per share, for a total transaction of $2,689,000.00. Following the completion of the acquisition, the director now owns 896,895 shares in the company, valued at approximately $24,117,506.55. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Craig R. Callen bought 10,000 shares of the stock in a transaction on Thursday, November 2nd. The stock was acquired at an average price of $27.38 per share, with a total value of $273,800.00. The disclosure for this purchase can be found here. Over the last ninety days, insiders purchased 210,000 shares of company stock worth $5,786,800. 1.54% of the stock is owned by insiders.

A number of hedge funds have recently modified their holdings of the business. State of Alaska Department of Revenue increased its holdings in Omega Healthcare Investors by 77.8% in the fourth quarter. State of Alaska Department of Revenue now owns 117,141 shares of the real estate investment trust’s stock worth $3,225,000 after purchasing an additional 51,250 shares in the last quarter. Creative Planning increased its holdings in Omega Healthcare Investors by 94.3% in the fourth quarter. Creative Planning now owns 45,942 shares of the real estate investment trust’s stock worth $1,265,000 after purchasing an additional 22,303 shares in the last quarter. Weaver C. Barksdale & Associates Inc. increased its holdings in Omega Healthcare Investors by 77.2% in the fourth quarter. Weaver C. Barksdale & Associates Inc. now owns 52,210 shares of the real estate investment trust’s stock worth $1,438,000 after purchasing an additional 22,743 shares in the last quarter. Atlantic Trust Group LLC increased its holdings in Omega Healthcare Investors by 176.1% in the third quarter. Atlantic Trust Group LLC now owns 61,782 shares of the real estate investment trust’s stock worth $1,971,000 after purchasing an additional 39,406 shares in the last quarter. Finally, New Mexico Educational Retirement Board increased its holdings in Omega Healthcare Investors by 30.9% in the third quarter. New Mexico Educational Retirement Board now owns 27,100 shares of the real estate investment trust’s stock worth $865,000 after purchasing an additional 6,400 shares in the last quarter. Institutional investors and hedge funds own 67.93% of the company’s stock.

WARNING: This piece of content was reported by Watch List News and is owned by of Watch List News. If you are reading this piece of content on another website, it was stolen and reposted in violation of United States and international copyright & trademark laws. The correct version of this piece of content can be read at https://www.watchlistnews.com/suntrust-banks-reaffirms-hold-rating-for-omega-healthcare-investors-ohi/1818266.html.

Omega Healthcare Investors Company Profile

Omega Healthcare Investors, Inc is a self-administered real estate investment trust (REIT). The Company maintains a portfolio of long-term healthcare facilities and mortgages on healthcare facilities located in the United States and the United Kingdom. It operates through the segment, which consists of investments in healthcare-related real estate properties.

Analyst Recommendations for Omega Healthcare Investors (NYSE:OHI)

Receive News & Ratings for Omega Healthcare Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Omega Healthcare Investors and related companies with MarketBeat.com's FREE daily email newsletter.